Stockscreener 앱 받기
2.69
0.37%
-0.01
시간 외 거래:
2.83
0.14
+5.20%
전일 마감가:
$2.70
열려 있는:
$2.63
하루 거래량:
18,581
Relative Volume:
0.36
시가총액:
$80.16M
수익:
$6.21M
순이익/손실:
$-19.92M
주가수익비율:
-2.5619
EPS:
-1.05
순현금흐름:
$-16.76M
1주 성능:
-1.82%
1개월 성능:
-16.46%
6개월 성능:
+0.37%
1년 성능:
+13.50%
1일 변동 폭
$2.60
$2.70
1주일 범위
$2.55
$2.80
52주 변동 폭
$1.81
$3.798
InspireMD Inc. Stock (NSPR) Company Profile
명칭
InspireMD Inc.
전화
972 3 6917691
주소
4 Menorat Hamaor Street, Tel Aviv
NSPR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NSPR
InspireMD Inc.
|
2.69 | 80.16M | 6.21M | -19.92M | -16.76M | -1.05 |
|
ABT
Abbott Laboratories
|
132.65 | 230.13B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.88 | 149.22B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
372.25 | 142.81B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.86 | 115.29B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.48 | 41.85B | 5.72B | 4.17B | 259.90M | 6.97 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2016-01-07 | 개시 | Rodman & Renshaw | Buy |
| 2015-03-13 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2013-11-26 | 개시 | Oppenheimer | Outperform |
InspireMD Inc. 주식(NSPR)의 최신 뉴스
InspireMD (NYSE:NSPR) Coverage Initiated at StockNews.com - Defense World
InspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare Conference - The Manila Times
Reviewing Anika Therapeutics (NASDAQ:ANIK) and InspireMD (NYSE:NSPR) - Defense World
InspireMD, Inc. (NSPR) Reports Q4 Loss, Tops Revenue Estimates - MSN
InspireMD, Inc. (NASDAQ:NSPR) Q4 2024 Earnings Call Transcript - Insider Monkey
InspireMD Inc (NSPR) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Rising Expenses and ... By GuruFocus - Investing.com Canada
InspireMD Inc. Reports 2024 Financial Results and Strategic Progress - TipRanks
InspireMD’s Earnings Call: Cautious Optimism Amid Challenges - TipRanks
InspireMD earnings beat by $0.01, revenue topped estimates - Investing.com Canada
Earnings call transcript: InspireMD Q4 2024 beats revenue forecast, stock rises - Investing.com India
InspireMD Inc reports results for the quarter ended December 31Earnings Summary - TradingView
InspireMD Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView
InspireMD reports Q4 EPS (19c) vs (16c) last year - TipRanks
INSPIREMD Earnings Results: $NSPR Reports Quarterly Earnings - Nasdaq
InspireMD Achieves Record $1.95M Revenue as FDA Approval Nears - StockTitan
InspireMD, Inc. SEC 10-K Report - TradingView
InspireMD (NYSE:NSPR) Now Covered by Analysts at StockNews.com - Defense World
InspireMD (NYSE:NSPR) and Bluejay Diagnostics (NASDAQ:BJDX) Head to Head Survey - Defense World
InspireMD (NYSE:NSPR) Now Covered by StockNews.com - Defense World
InspireMD, Inc. to Host Earnings Call - ACCESS Newswire
InspireMD announces inducement grants under Nasdaq listing rule - MSN
InspireMD to Announce Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
When Will InspireMD Release Its 2024 Results? Key Date for Carotid Stent Maker Announced - StockTitan
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Is InspireMD's Hiring Spree a Signal for Investors? Company Awards 138K Shares to New Talent - StockTitan
Investors in InspireMD (NASDAQ:NSPR) have unfortunately lost 78% over the last five years - Yahoo Finance
NSPR stock touches 52-week high at $3.43 amid robust growth - Investing.com
InspireMD and NAMSA to begin study of carotid stent system for TCAR procedures - Yahoo
InspireMD and NAMSA to Partner on CGUARDIANS II Pivotal - GlobeNewswire
InspireMD And NAMSA To Partner On CGuardians II Pivotal Clinical Trial Of The CGuard Prime 80 Cm Carotid Stent System For Use In TCAR Procedures - Marketscreener.com
Major Clinical Trial Alert: InspireMD's Revolutionary TCAR Stent Targets $1B+ Market - StockTitan
StockNews.com Begins Coverage on InspireMD (NYSE:NSPR) - Defense World
Investors in InspireMD (NASDAQ:NSPR) from five years ago are still down 86%, even after 10% gain this past week - Simply Wall St
Compliance Issues And Stock Developments Hit Nasdaq Companies - Evrim Ağacı
InspireMD Awards Strategic Employee Stock Grants to Accelerate Growth, Adds 9 New Hires - StockTitan
StockNews.com Initiates Coverage on InspireMD (NYSE:NSPR) - Defense World
InspireMD : Breakthrough device in clinical trials aims to prevent strokes -January 20, 2025 at 07:59 am EST - Marketscreener.com
Here's Why We're Watching InspireMD's (NASDAQ:NSPR) Cash Burn Situation - Yahoo Finance
InspireMD (NYSE:NSPR) Coverage Initiated by Analysts at StockNews.com - MarketBeat
InspireMD Inc. (NSPR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.64%
0.94%
자본화:
|
볼륨(24시간):